{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:25:33Z","timestamp":1787286333794,"version":"build-2736575974"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007378","name":"Universidade Federal De Juiz De Fora","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007378","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer (CRC) is a multifactorial disease strongly influenced by genetic and environmental factors, as well as by immune and metabolic disorders such as obesity and gut dysbiosis. Recent evidence highlights the interplay between the endocannabinoidome (eCBome) and the gut microbiota as a central regulatory axis of intestinal homeostasis, metabolism, and immune responses. Although no studies have directly investigated this functional interaction in the CRC context, recent evidence suggests that dysfunction of the eCBome\u2013microbiota axis, commonly observed in obesity, may influence colorectal tumorigenesis by impairing intestinal barrier integrity, increasing endotoxemia and immune dysregulation, altering microbial metabolite production, and activating NF-\u03baB-mediated pro-tumorigenic signaling pathway. This is the first review to comprehensively integrate current evidence linking obesity-associated eCBome\u2013microbiota dysfunction with CRC-related mechanisms and to propose potential pathways through which this interaction may influence CRC pathogenesis, providing a framework to guide future studies and support the development of novel preventive and therapeutic strategies for CRC.<\/jats:p>","DOI":"10.1007\/s13105-026-01225-8","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:07:19Z","timestamp":1787285239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The endocannabinoidome\u2013microbiota axis in obesity: a potential link to colorectal cancer development"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3102-7882","authenticated-orcid":false,"given":"Gabriela","family":"\u00c1vila Alpino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1048-7831","authenticated-orcid":false,"given":"Poliana Guiomar","family":"Brasiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-3105","authenticated-orcid":false,"given":"Mariana M.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-5337","authenticated-orcid":false,"given":"Sheila C. P.","family":"Dutra Luquetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"16","key":"1225_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168836","volume":"25","author":"L Gonzalez-Gutierrez","year":"2024","unstructured":"Gonzalez-Gutierrez L, Moti\u00f1o O, Barriuso D et al (2024) Obesity-associated colorectal cancer. Int J Mol Sci 25(16):8836. https:\/\/doi.org\/10.3390\/ijms25168836","journal-title":"Int J Mol Sci"},{"key":"1225_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A et al (2023) Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72:338\u2013344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736","journal-title":"Gut"},{"key":"1225_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E (2019) Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 16:713\u2013732. https:\/\/doi.org\/10.1038\/s41575-019-0189-8","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1225_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1370108","volume":"12","author":"AM Atchade","year":"2024","unstructured":"Atchade AM, Williams JL, Mermelstein L et al (2024) Unraveling the complexities of early-onset colorectal cancer: a perspective on dietary and microbial influences. Front Public Health 12:1370108. https:\/\/doi.org\/10.3389\/fpubh.2024.1370108","journal-title":"Front Public Health"},{"key":"1225_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J (2023) Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol 20:429\u2013452. https:\/\/doi.org\/10.1038\/s41571-023-00766-x","journal-title":"Nat Rev Clin Oncol"},{"key":"1225_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.psyneuen.2019.02.004","volume":"103","author":"MM Almeida","year":"2019","unstructured":"Almeida MM, Dias-Rocha CP, Reis-Gomes CF et al (2019) Maternal high-fat diet impairs leptin signaling and up-regulates type-1 cannabinoid receptor with sex-specific epigenetic changes in the hypothalamus of newborn rats. Psychoneuroendocrinology 103:306\u2013315. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.02.004","journal-title":"Psychoneuroendocrinology"},{"key":"1225_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00394-020-02318-w","volume":"60","author":"MM Almeida","year":"2021","unstructured":"Almeida MM, Dias-Rocha CP, Reis-Gomes CF et al (2021) Maternal high-fat diet up-regulates type-1 cannabinoid receptor with estrogen signaling changes in a sex- and depot-specific manner in white adipose tissue of adult rat offspring. Eur J Nutr 60:1313\u20131326. https:\/\/doi.org\/10.1007\/s00394-020-02318-w","journal-title":"Eur J Nutr"},{"key":"1225_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109802","volume":"126","author":"MM Almeida","year":"2025","unstructured":"Almeida MM, Calvi\u00f1o C, Reis-Gomes CF et al (2025) Maternal obesity changes the small intestine endocannabinoid system and fecal metabolites of weanling rats associated with reduced intestinal permeability and impaired glucose homeostasis. J Nutr Biochem 126:109802. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109802","journal-title":"J Nutr Biochem"},{"key":"1225_CR9","doi-asserted-by":"publisher","first-page":"1566290","DOI":"10.3389\/fcimb.2025.1566290","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Guo J, Mao Z, Chen Y (2025) Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective. Front Cell Infect Microbiol 15:1566290. https:\/\/doi.org\/10.3389\/fcimb.2025.1566290","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"1225_CR10","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3390\/ijms26031306","volume":"26","author":"EA Caruso","year":"2025","unstructured":"Caruso EA, De Nunzio V, Tutino V et al (2025) The endocannabinoid system: implications in gastrointestinal physiology and pathology. Int J Mol Sci 26(7):1306. https:\/\/doi.org\/10.3390\/ijms26031306","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1225_CR11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.jcmgh.2022.05.015","volume":"14","author":"H Cuddihey","year":"2022","unstructured":"Cuddihey H, MacNaughton WK, Sharkey KA (2022) Role of the endocannabinoid system in the regulation of intestinal homeostasis. Cell Mol Gastroenterol Hepatol 14(4):947\u2013963. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.05.015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1225_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873\u2013884. https:\/\/doi.org\/10.1038\/nrn1247","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"1225_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","volume":"22","author":"M Duncan","year":"2005","unstructured":"Duncan M, Davison JS, Sharkey KA (2005) Endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 22(8):667\u2013683. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02648.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1225_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/blutz","volume":"22","author":"B Lutz","year":"2020","unstructured":"Lutz B (2020) Neurobiology of cannabinoid receptor signaling. Dialogues Clin Neurosci 22(3):207\u2013222. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/blutz","journal-title":"Dialogues Clin Neurosci"},{"issue":"3","key":"1225_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.31887\/DCNS.2020.22.3\/vdimarzo","volume":"22","author":"V Di Marzo","year":"2020","unstructured":"Di Marzo V (2020) The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders. Dialogues Clin Neurosci 22(3):259\u2013269. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/vdimarzo","journal-title":"Dialogues Clin Neurosci"},{"issue":"8","key":"1225_CR16","doi-asserted-by":"publisher","first-page":"e6893","DOI":"10.1371\/journal.pone.0006893","volume":"4","author":"L Marqu\u00e9z","year":"2009","unstructured":"Marqu\u00e9z L, Su\u00e1rez J, Iglesias M et al (2009) Ulcerative colitis induces changes on the expression of the endocannabinoid system in human colonic tissue. PLoS ONE 4(8):e6893. https:\/\/doi.org\/10.1371\/journal.pone.0006893","journal-title":"PLoS ONE"},{"issue":"1","key":"1225_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","volume":"126","author":"AA Izzo","year":"2010","unstructured":"Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126(1):21\u201338. https:\/\/doi.org\/10.1016\/j.pharmthera.2009.12.005","journal-title":"Pharmacol Ther"},{"issue":"17","key":"1225_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174353","volume":"13","author":"V Cherkasova","year":"2021","unstructured":"Cherkasova V, Kovalchuk O, Kovalchuk I (2021) Cannabinoids and endocannabinoid system changes in intestinal inflammation and colorectal cancer. Cancers 13(17):4353. https:\/\/doi.org\/10.3390\/cancers13174353","journal-title":"Cancers"},{"key":"1225_CR19","doi-asserted-by":"publisher","first-page":"110169","DOI":"10.1016\/j.pnpbp.2020.110169","volume":"106","author":"J Jansma","year":"2020","unstructured":"Jansma J, Brinkman F, van Hemert S et al (2020) Targeting the endocannabinoid system with microbial interventions to improve gut integrity. Prog Neuropsychopharmacol Biol Psychiatry 106:110169. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110169","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"1225_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0014-2999(02)02053-8","volume":"450","author":"M Landi","year":"2002","unstructured":"Landi M, Croci T, Rinaldi-Carmona M et al (2002) Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB\u2081 receptors. Eur J Pharmacol 450(1):77\u201383. https:\/\/doi.org\/10.1016\/s0014-2999(02)02053-8","journal-title":"Eur J Pharmacol"},{"issue":"30","key":"1225_CR21","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1523\/JNEUROSCI.4507-11.2012","volume":"32","author":"CR Vianna","year":"2012","unstructured":"Vianna CR, Donato J Jr, Rossi J et al (2012) Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility. J Neurosci 32(30):10331\u201310337. https:\/\/doi.org\/10.1523\/JNEUROSCI.4507-11.2012","journal-title":"J Neurosci"},{"issue":"3","key":"1225_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/j.gastro.2005.06.018","volume":"129","author":"R Capasso","year":"2005","unstructured":"Capasso R, Matias I, Lutz B et al (2005) Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 129(3):941\u2013951. https:\/\/doi.org\/10.1053\/j.gastro.2005.06.018","journal-title":"Gastroenterology"},{"issue":"1\u20133","key":"1225_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejphar.2007.07.036","volume":"575","author":"SD Smid","year":"2007","unstructured":"Smid SD, Bjorklund CK, Svensson KM et al (2007) The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon. Eur J Pharmacol 575(1\u20133):168\u2013176. https:\/\/doi.org\/10.1016\/j.ejphar.2007.07.036","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1225_CR24","doi-asserted-by":"publisher","first-page":"G78","DOI":"10.1152\/ajpgi.90285.2008","volume":"295","author":"M Duncan","year":"2008","unstructured":"Duncan M, Mouihate A, Mackie K et al (2008) Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am J Physiol Gastrointest Liver Physiol 295(1):G78\u2013G87. https:\/\/doi.org\/10.1152\/ajpgi.90285.2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1225_CR25","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/msb.2010.46","volume":"6","author":"GG Muccioli","year":"2010","unstructured":"Muccioli GG, Naslain D, B\u00e4ckhed F et al (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6:392. https:\/\/doi.org\/10.1038\/msb.2010.46","journal-title":"Mol Syst Biol"},{"key":"1225_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658681","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu L, Liu Y, Kong X, Wu R, Peng Q, Zhang Y et al (2021) Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4\/NF-\u03baB\/S100A9 cascade. Front Immunol 12:658681. https:\/\/doi.org\/10.3389\/fimmu.2021.658681","journal-title":"Front Immunol"},{"issue":"8","key":"1225_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B et al (2019) The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1225_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1124\/jpet.110.168237","volume":"335","author":"A Alhamoruni","year":"2010","unstructured":"Alhamoruni A, Lee AC, Wright KL et al (2010) Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability. J Pharmacol Exp Ther 335(1):92\u2013102. https:\/\/doi.org\/10.1124\/jpet.110.168237","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"1225_CR29","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1111\/j.1476-5381.2011.01589.x","volume":"165","author":"A Alhamoruni","year":"2012","unstructured":"Alhamoruni A, Wright KL, Larvin M et al (2012) Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. Br J Pharmacol 165(8):2598\u20132610. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01589.x","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1225_CR30","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1096\/fj.10-176602","volume":"25","author":"M Alhouayek","year":"2011","unstructured":"Alhouayek M, Lambert DM, Delzenne NM et al (2011) Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J 25(8):2711\u20132721. https:\/\/doi.org\/10.1096\/fj.10-176602","journal-title":"FASEB J"},{"issue":"4","key":"1225_CR31","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.bbrc.2020.02.173","volume":"525","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang X, Yang C et al (2020) Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model. Biochem Biophys Res Commun 525(4):962\u2013967. https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.173","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"1225_CR32","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard A, Belzer C, Geurts L et al (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110(22):9066\u20139071. https:\/\/doi.org\/10.1073\/pnas.1219451110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1225_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrendo.2015.211","volume":"12","author":"P Cani","year":"2016","unstructured":"Cani P, Plovier H, Van Hul M et al (2016) Endocannabinoids \u2014at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol 12:133\u2013143. https:\/\/doi.org\/10.1038\/nrendo.2015.211","journal-title":"Nat Rev Endocrinol"},{"key":"1225_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109802","volume":"136","author":"MM Almeida","year":"2025","unstructured":"Almeida MM, Calvi\u00f1o C, Reis-Gomes CF et al (2025) Maternal obesity changes the small intestine endocannabinoid system and fecal metabolites of weanling rats associated with reduced intestinal permeability and impaired glucose homeostasis. J Nutr Biochem 136:109802. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109802","journal-title":"J Nutr Biochem"},{"key":"1225_CR35","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1096\/fj.10-176602","volume":"25","author":"M Alhouayek","year":"2011","unstructured":"Alhouayek M, Lambert DM, Delzenne NM et al (2011) Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J 25:2711\u20132721. https:\/\/doi.org\/10.1096\/fj.10-176602","journal-title":"FASEB J"},{"issue":"1","key":"1225_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bph.12907","volume":"172","author":"F Borrelli","year":"2015","unstructured":"Borrelli F, Romano B, Petrosino S et al (2015) Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol 172(1):142\u2013158. https:\/\/doi.org\/10.1111\/bph.12907","journal-title":"Br J Pharmacol"},{"key":"1225_CR37","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00011-019-01231-1","volume":"68","author":"J Korbecki","year":"2019","unstructured":"Korbecki J, Bobi\u0144ski R, Dutka M (2019) Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflamm Res 68:443\u2013458. https:\/\/doi.org\/10.1007\/s00011-019-01231-1","journal-title":"Inflamm Res"},{"key":"1225_CR38","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/gutjnl-2013-305005","volume":"63","author":"G Esposito","year":"2014","unstructured":"Esposito G, Capoccia E, Turco F et al (2014) Palmitoylethanolamide improves colon inflammation through an enteric glia\/Toll-like receptor 4-dependent PPAR-\u03b1 activation. Gut 63:1300\u20131312. https:\/\/doi.org\/10.1136\/gutjnl-2013-305005","journal-title":"Gut"},{"issue":"19","key":"1225_CR39","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1073\/pnas.1612177114","volume":"114","author":"N Acharya","year":"2017","unstructured":"Acharya N, Penukonda S, Shcheglova T et al (2017) Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Proc Natl Acad Sci U S A 114(19):5005\u20135010. https:\/\/doi.org\/10.1073\/pnas.1612177114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1225_CR40","doi-asserted-by":"publisher","first-page":"867267","DOI":"10.3389\/fncel.2022.867267","volume":"16","author":"RK Srivastava","year":"2022","unstructured":"Srivastava RK, Lutz B, Ruiz de Azua I (2022) The microbiome and gut endocannabinoid system in the regulation of stress responses and metabolism. Front Cell Neurosci 16:867267. https:\/\/doi.org\/10.3389\/fncel.2022.867267","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"1225_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041214","volume":"13","author":"NV DiPatrizio","year":"2021","unstructured":"DiPatrizio NV (2021) Endocannabinoids and the gut-brain control of food intake and obesity. Nutrients 13(4):1214. https:\/\/doi.org\/10.3390\/nu13041214","journal-title":"Nutrients"},{"issue":"4","key":"1225_CR42","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"TC Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, and feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136(4):550\u2013557. https:\/\/doi.org\/10.1038\/sj.bjp.0704767","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1225_CR43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","volume":"3","author":"HA Overton","year":"2006","unstructured":"Overton HA, Babbs AJ, Doel SM et al (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3(3):167\u2013175. https:\/\/doi.org\/10.1016\/j.cmet.2006.02.004","journal-title":"Cell Metab"},{"issue":"5","key":"1225_CR44","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.2337\/db08-1237","volume":"58","author":"LM Lauffer","year":"2009","unstructured":"Lauffer LM, Iakoubov R, Brubaker PL (2009) GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58(5):1058\u20131066. https:\/\/doi.org\/10.2337\/db08-1237","journal-title":"Diabetes"},{"issue":"5","key":"1225_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.phrs.2003.12.006","volume":"49","author":"F Oveisi","year":"2004","unstructured":"Oveisi F, Gaetani S, Eng KT et al (2004) Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration. Pharmacol Res 49(5):461\u2013466. https:\/\/doi.org\/10.1016\/j.phrs.2003.12.006","journal-title":"Pharmacol Res"},{"key":"1225_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V et al (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19:275\u2013293. https:\/\/doi.org\/10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"issue":"8","key":"1225_CR47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","volume":"17","author":"M Schirmer","year":"2019","unstructured":"Schirmer M, Garner A, Vlamakis H et al (2019) Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol 17(8):497\u2013511. https:\/\/doi.org\/10.1038\/s41579-019-0213-6","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"1225_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5114\/pg.2018.81072","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Prz Gastroenterol 14(2):89\u2013103. https:\/\/doi.org\/10.5114\/pg.2018.81072","journal-title":"Prz Gastroenterol"},{"issue":"10218","key":"1225_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","volume":"395","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n O, Erichsen R, Sachs MC et al (2020) Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. Lancet 395(10218):123\u2013131. https:\/\/doi.org\/10.1016\/S0140-6736(19)32545-0","journal-title":"Lancet"},{"issue":"5","key":"1225_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2468-1253(20)30005-4","volume":"5","author":"O Ol\u00e9n","year":"2020","unstructured":"Ol\u00e9n O, Erichsen R, Sachs MC et al (2020) Colorectal cancer in Crohn\u2019s disease: a Scandinavian population-based cohort study. Lancet Gastroenterol Hepatol 5(5):475\u2013484. https:\/\/doi.org\/10.1016\/S2468-1253(20)30005-4","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"1225_CR51","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jama.2015.0954","volume":"313","author":"WD Chey","year":"2015","unstructured":"Chey WD, Kurlander J, Eswaran S (2015) Irritable bowel syndrome. JAMA 313(9):949\u2013958. https:\/\/doi.org\/10.1001\/jama.2015.0954","journal-title":"JAMA"},{"key":"1225_CR52","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1111\/ans.18223","volume":"93","author":"D Wickramasinghe","year":"2023","unstructured":"Wickramasinghe D, Kamburugamuwa S, Xavier C et al (2023) Prevalence of irritable bowel syndrome and its association with colorectal cancer: A systematic review and meta-analysis. ANZ J Surg 93:1480\u20131486. https:\/\/doi.org\/10.1111\/ans.18223","journal-title":"ANZ J Surg"},{"key":"1225_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.639728","volume":"12","author":"G Esposito","year":"2021","unstructured":"Esposito G, Corpetti C, Pesce M et al (2021) A palmitoylethanolamide-producing Lactobacillus paracasei improves Clostridium difficile toxin A-induced colitis. Front Pharmacol 12:639728. https:\/\/doi.org\/10.3389\/fphar.2021.639728","journal-title":"Front Pharmacol"},{"key":"1225_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1143004","volume":"10","author":"C Pirozzi","year":"2023","unstructured":"Pirozzi C, Coretti L, Opallo N et al (2023) Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism. Front Nutr 10:1143004. https:\/\/doi.org\/10.3389\/fnut.2023.1143004","journal-title":"Front Nutr"},{"issue":"5","key":"1225_CR55","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/antiox13050600","volume":"13","author":"M Brankovi\u0107","year":"2024","unstructured":"Brankovi\u0107 M, Gmizi\u0107 T, Duki\u0107 M et al (2024) Therapeutic potential of palmitoylethanolamide in gastrointestinal disorders. Antioxidants 13(5):600. https:\/\/doi.org\/10.3390\/antiox13050600","journal-title":"Antioxidants"},{"issue":"10","key":"1225_CR56","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.intimp.2010.07.007","volume":"10","author":"YT Azuma","year":"2010","unstructured":"Azuma YT, Nishiyama K, Matsuo Y et al (2010) PPAR\u03b1 contributes to colonic protection in mice with DSS-induced colitis. Int Immunopharmacol 10(10):1261\u20131267. https:\/\/doi.org\/10.1016\/j.intimp.2010.07.007","journal-title":"Int Immunopharmacol"},{"key":"1225_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ni.1825","volume":"11","author":"NH Salzman","year":"2010","unstructured":"Salzman NH, Hung K, Haribhai D et al (2010) Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11:76\u201383. https:\/\/doi.org\/10.1038\/ni.1825","journal-title":"Nat Immunol"},{"key":"1225_CR58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41564-019-0655-7","volume":"5","author":"N Fornelos","year":"2020","unstructured":"Fornelos N, Franzosa EA, Bishai J et al (2020) Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease. Nat Microbiol 5:486\u2013497. https:\/\/doi.org\/10.1038\/s41564-019-0655-7","journal-title":"Nat Microbiol"},{"issue":"1","key":"1225_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nm1521","volume":"13","author":"C Rousseaux","year":"2007","unstructured":"Rousseaux C, Thuru X, Gelot A et al (2007) Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13(1):35\u201337. https:\/\/doi.org\/10.1038\/nm1521","journal-title":"Nat Med"},{"issue":"2","key":"1225_CR60","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/gut.2008.157594","volume":"58","author":"S Hong","year":"2009","unstructured":"Hong S, Fan J, Kemmerer ES et al (2009) Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat. Gut 58(2):202\u2013210. https:\/\/doi.org\/10.1136\/gut.2008.157594","journal-title":"Gut"},{"key":"1225_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1689597","volume":"16","author":"SH Liu","year":"2025","unstructured":"Liu SH, Yang XF, Liang L, Song BB, Song XM, Yang YJ et al (2025) Regulatory mechanisms of the gut microbiota-short chain fatty acids signaling axis in slow transit constipation and progress in multi-target interventions. Front Microbiol 16:1689597. https:\/\/doi.org\/10.3389\/fmicb.2025.1689597","journal-title":"Front Microbiol"},{"issue":"1","key":"1225_CR62","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1997559","volume":"13","author":"A Vijay","year":"2021","unstructured":"Vijay A, Kouraki A, Gohir S et al (2021) The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids. Gut Microbes 13(1):1997559. https:\/\/doi.org\/10.1080\/19490976.2021.1997559","journal-title":"Gut Microbes"},{"issue":"4","key":"1225_CR63","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1038\/ctg.2012.8","volume":"3","author":"M Manocha","year":"2012","unstructured":"Manocha M, Khan WI (2012) Serotonin and GI disorders: an update on clinical and experimental studies. Clin Transl Gastroenterol 3(4):e13. https:\/\/doi.org\/10.1038\/ctg.2012.8","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"1225_CR64","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.7150\/thno.70762","volume":"12","author":"L Mao","year":"2022","unstructured":"Mao L, Xin F, Ren J et al (2022) 5-HT2B-mediated serotonin activation in enterocytes suppresses colitis-associated cancer initiation and promotes cancer progression. Theranostics 12(8):3928\u20133945. https:\/\/doi.org\/10.7150\/thno.70762","journal-title":"Theranostics"},{"issue":"1","key":"1225_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/19490976.2014.990790","volume":"6","author":"M Aguilera","year":"2015","unstructured":"Aguilera M, Cerd\u00e0-Cu\u00e9llar M, Mart\u00ednez V (2015) Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes 6(1):10\u201323. https:\/\/doi.org\/10.4161\/19490976.2014.990790","journal-title":"Gut Microbes"},{"issue":"6","key":"1225_CR66","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/19490976.2017.1353849","volume":"8","author":"AT Mudd","year":"2017","unstructured":"Mudd AT, Berding K, Wang M et al (2017) Serum cortisol mediates the relationship between fecal Ruminococcus and brain N-acetylaspartate in the young pig. Gut Microbes 8(6):589\u2013600. https:\/\/doi.org\/10.1080\/19490976.2017.1353849","journal-title":"Gut Microbes"},{"issue":"1","key":"1225_CR67","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1194\/jlr.RA119000424","volume":"61","author":"C Manca","year":"2020","unstructured":"Manca C, Boubertakh B, Leblanc N et al (2020) Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. J Lipid Res 61(1):70\u201385. https:\/\/doi.org\/10.1194\/jlr.RA119000424","journal-title":"J Lipid Res"},{"issue":"1","key":"1225_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72861-3","volume":"10","author":"S Castonguay-Paradis","year":"2020","unstructured":"Castonguay-Paradis S, Lacroix S, Rochefort G et al (2020) Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat. Sci Rep 10(1):15975. https:\/\/doi.org\/10.1038\/s41598-020-72861-3","journal-title":"Sci Rep"},{"issue":"10","key":"1225_CR69","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.3390\/nu14102143","volume":"14","author":"L Ortiz-Alvarez","year":"2022","unstructured":"Ortiz-Alvarez L, Xu H, Di X et al (2022) Plasma levels of endocannabinoids and their analogues are related to specific fecal bacterial genera in young adults: Role in gut barrier integrity. Nutrients 14(10):2143. https:\/\/doi.org\/10.3390\/nu14102143","journal-title":"Nutrients"},{"issue":"3","key":"1225_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ani14030493","volume":"14","author":"Z Yin","year":"2024","unstructured":"Yin Z, Wang K, Liu Y et al (2024) Lactobacillus johnsonii improves intestinal barrier function and reduces post-weaning diarrhea in piglets: involvement of the endocannabinoid system. Animals (Basel) 14(3):493. https:\/\/doi.org\/10.3390\/ani14030493","journal-title":"Animals (Basel)"},{"issue":"1","key":"1225_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15154-6","volume":"7","author":"P Mehrpouya-Bahrami","year":"2017","unstructured":"Mehrpouya-Bahrami P, Chitrala KN, Ganewatta MS et al (2017) Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity. Sci Rep 7(1):15645. https:\/\/doi.org\/10.1038\/s41598-017-15154-6","journal-title":"Sci Rep"},{"key":"1225_CR72","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1096\/fj.201801203R","volume":"33","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Kita Y, Tokuoka SM et al (2019) Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice. FASEB J 33:2484\u20132497. https:\/\/doi.org\/10.1096\/fj.201801203R","journal-title":"FASEB J"},{"key":"1225_CR73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41467-018-08051-7","volume":"10","author":"A Everard","year":"2019","unstructured":"Everard A, Plovier H, Rastelli M et al (2019) Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nat Commun 10:457. https:\/\/doi.org\/10.1038\/s41467-018-08051-7","journal-title":"Nat Commun"},{"issue":"12","key":"1225_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122705","volume":"9","author":"N Dione","year":"2020","unstructured":"Dione N, Lacroix S, Taschler U et al (2020) Mgll knockout mouse resistance to diet-induced dysmetabolism is associated with altered gut microbiota. Cells 9(12):2705. https:\/\/doi.org\/10.3390\/cells9122705","journal-title":"Cells"},{"issue":"4","key":"1225_CR75","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.clnu.2019.05.020","volume":"39","author":"M Chen","year":"2020","unstructured":"Chen M, Hou P, Zhou M et al (2020) Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clin Nutr 39(4):1264\u20131275. https:\/\/doi.org\/10.1016\/j.clnu.2019.05.020","journal-title":"Clin Nutr"},{"key":"1225_CR76","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00407-19","volume":"4","author":"S Lacroix","year":"2019","unstructured":"Lacroix S, Pechereau F, Leblanc N et al (2019) Rapid and concomitant gut microbiota and endocannabinoidome response to diet-induced obesity in mice. mSystems 4:e00407-19. https:\/\/doi.org\/10.1128\/mSystems.00407-19","journal-title":"mSystems"},{"issue":"7","key":"1225_CR77","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1007\/s00394-021-02538-8","volume":"60","author":"S Tagliamonte","year":"2021","unstructured":"Tagliamonte S, Laiola M, Ferracane R et al (2021) Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation. Eur J Nutr 60(7):3703\u20133716. https:\/\/doi.org\/10.1007\/s00394-021-02538-8","journal-title":"Eur J Nutr"},{"issue":"82","key":"1225_CR78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molmet.2018.06.002","volume":"14","author":"F Fanelli","year":"2018","unstructured":"Fanelli F, Mezzullo M, Repaci A et al (2018) Profiling plasma N-acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism. Mol Metab 14(82):82\u201394. https:\/\/doi.org\/10.1016\/j.molmet.2018.06.002","journal-title":"Mol Metab"},{"issue":"3","key":"1225_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008792","volume":"5","author":"JC Sipe","year":"2010","unstructured":"Sipe JC, Scott TM, Murray S et al (2010) Biomarkers of endocannabinoid system activation in severe obesity. PLoS ONE 5(3):e8792. https:\/\/doi.org\/10.1371\/journal.pone.0008792","journal-title":"PLoS ONE"},{"issue":"10","key":"1225_CR80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11892-017-0924-x","volume":"17","author":"JM Richey","year":"2017","unstructured":"Richey JM, Woolcott O (2017) Re-visiting the endocannabinoid system and its therapeutic potential in obesity and associated diseases. Curr Diab Rep 17(10):99. https:\/\/doi.org\/10.1007\/s11892-017-0924-x","journal-title":"Curr Diab Rep"},{"issue":"2","key":"1225_CR81","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L et al (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14(2):207\u2013215. https:\/\/doi.org\/10.1016\/j.chom.2013.07.007","journal-title":"Cell Host Microbe"},{"key":"1225_CR82","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373\u2013384. https:\/\/doi.org\/10.1038\/ni.1863","journal-title":"Nat Immunol"},{"key":"1225_CR83","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/s41564-019-0541-3","volume":"4","author":"X Long","year":"2019","unstructured":"Long X, Wong CC, Tong L, Chu ESH, Ho Szeto C, Go MYY et al (2019) Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity. Nat Microbiol 4:2319\u20132330. https:\/\/doi.org\/10.1038\/s41564-019-0541-3","journal-title":"Nat Microbiol"},{"key":"1225_CR84","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/ncomms6648","volume":"5","author":"A Everard","year":"2014","unstructured":"Everard A, Geurts L, Caesar R et al (2014) Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun 5:5648. https:\/\/doi.org\/10.1038\/ncomms6648","journal-title":"Nat Commun"},{"key":"1225_CR85","doi-asserted-by":"publisher","first-page":"1025706","DOI":"10.3389\/fendo.2022.1025706","volume":"13","author":"Z Cheng","year":"2022","unstructured":"Cheng Z, Zhang L, Yang L et al (2022) The critical role of gut microbiota in obesity. Front Endocrinol 13:1025706. https:\/\/doi.org\/10.3389\/fendo.2022.1025706","journal-title":"Front Endocrinol"},{"issue":"10","key":"1225_CR86","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1158\/2326-6066.CIR-20-1019","volume":"9","author":"L Fan","year":"2021","unstructured":"Fan L, Xu C, Ge Q et al (2021) Akkermansia muciniphila suppresses colorectal tumorigenesis by inducing TLR2\/NLRP3-mediated M1-like TAMs. Cancer Immunol Res 9(10):1111\u20131124. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-1019","journal-title":"Cancer Immunol Res"},{"issue":"14","key":"1225_CR87","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.7150\/ijbs.85712","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang L, Ji Q, Chen Q et al (2023) Akkermansia muciniphila inhibits tryptophan metabolism via the AhR\/\u03b2-catenin signaling pathway to counter the progression of colorectal cancer. Int J Biol Sci 19(14):4393\u20134410. https:\/\/doi.org\/10.7150\/ijbs.85712","journal-title":"Int J Biol Sci"},{"issue":"5","key":"1225_CR88","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1158\/0008-5472.CAN-22-3705","volume":"84","author":"Q Cao","year":"2024","unstructured":"Cao Q, Zhao M, Su Y et al (2024) Chronic stress dampens Lactobacillus johnsonii-mediated tumor suppression to enhance colorectal cancer progression. Cancer Res 84(5):771\u2013784. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3705","journal-title":"Cancer Res"},{"key":"1225_CR89","doi-asserted-by":"publisher","first-page":"104301","DOI":"10.1016\/j.appet.2019.05.032","volume":"141","author":"L Payahoo","year":"2019","unstructured":"Payahoo L, Khajebishak Y, Alivand MR et al (2019) Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: a randomized clinical trial. Appetite 141:104301. https:\/\/doi.org\/10.1016\/j.appet.2019.05.032","journal-title":"Appetite"},{"issue":"3","key":"1225_CR90","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/s0016-5085(03)00881-3","volume":"125","author":"A Ligresti","year":"2003","unstructured":"Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG et al (2003) Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125(3):677\u2013687. https:\/\/doi.org\/10.1016\/s0016-5085(03)00881-3","journal-title":"Gastroenterology"},{"issue":"15","key":"1225_CR91","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1158\/0008-5472.CAN-08-0896","volume":"68","author":"D Wang","year":"2009","unstructured":"Wang D, Wang H, Ning W et al (2009) Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res 68(15):6468\u20136476. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0896","journal-title":"Cancer Res"},{"issue":"5","key":"1225_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050708","volume":"11","author":"V Tutino","year":"2019","unstructured":"Tutino V, Caruso MG, De Nunzio V et al (2019) Down-regulation of cannabinoid type 1 (CB1) receptor and its downstream signaling pathways in metastatic colorectal cancer. Cancers 11(5):708. https:\/\/doi.org\/10.3390\/cancers11050708","journal-title":"Cancers"},{"issue":"4","key":"1225_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044060","volume":"24","author":"JA Iden","year":"2023","unstructured":"Iden JA, Raphael-Mizrahi B, Awida Z et al (2023) The anti-tumorigenic role of cannabinoid receptor 2 in colon cancer: a study in mice and humans. Int J Mol Sci 24(4):4060. https:\/\/doi.org\/10.3390\/ijms24044060","journal-title":"Int J Mol Sci"},{"issue":"23","key":"1225_CR94","doi-asserted-by":"publisher","first-page":"7691","DOI":"10.1158\/1078-0432.CCR-08-0799","volume":"14","author":"F Cianchi","year":"2008","unstructured":"Cianchi F, Papucci L, Schiavone N et al (2008) Cannabinoid receptor activation induces apoptosis through tumor necrosis factor \u03b1-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 14(23):7691\u20137700. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0799","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1225_CR95","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1007\/s11010-021-04158-6","volume":"476","author":"A Alenabi","year":"2021","unstructured":"Alenabi A, Malekinejad H (2021) Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29). Mol Cell Biochem 476(9):3285\u20133301. https:\/\/doi.org\/10.1007\/s11010-021-04158-6","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1225_CR96","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ijc.31030","volume":"142","author":"C Hasenoehrl","year":"2018","unstructured":"Hasenoehrl C, Feuersinger D, Sturm EM et al (2018) G-protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1. Int J Cancer 142(1):121\u2013132. https:\/\/doi.org\/10.1002\/ijc.31030","journal-title":"Int J Cancer"},{"issue":"3","key":"1225_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008702","volume":"5","author":"E Cudaback","year":"2010","unstructured":"Cudaback E, Marrs W, Moeller T et al (2010) The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS One 5(3):e8702. https:\/\/doi.org\/10.1371\/journal.pone.0008702","journal-title":"PLoS One"},{"issue":"42","key":"1225_CR98","doi-asserted-by":"publisher","first-page":"68781","DOI":"10.18632\/oncotarget.11968","volume":"7","author":"E Mart\u00ednez-Mart\u00ednez","year":"2016","unstructured":"Mart\u00ednez-Mart\u00ednez E, Mart\u00edn-Ruiz A, Mart\u00edn P et al (2016) CB2 cannabinoid receptor activation promotes colon cancer progression via AKT\/GSK3\u03b2 signaling pathway. Oncotarget 7(42):68781\u201368791. https:\/\/doi.org\/10.18632\/oncotarget.11968","journal-title":"Oncotarget"},{"issue":"1","key":"1225_CR99","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/or.2015.3973","volume":"34","author":"L Chen","year":"2015","unstructured":"Chen L, Chen H, Li Y et al (2015) Endocannabinoid and ceramide levels are altered in patients with colorectal cancer. Oncol Rep 34(1):447\u2013454. https:\/\/doi.org\/10.3892\/or.2015.3973","journal-title":"Oncol Rep"},{"issue":"7","key":"1225_CR100","first-page":"2583","volume":"30","author":"M Linsalata","year":"2010","unstructured":"Linsalata M, Notarnicola M, Tutino V et al (2010) Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. Anticancer Res 30(7):2583\u20132589","journal-title":"Anticancer Res"},{"issue":"48","key":"1225_CR101","doi-asserted-by":"publisher","first-page":"44877","DOI":"10.1074\/jbc.M206788200","volume":"277","author":"KR Kozak","year":"2002","unstructured":"Kozak KR, Crews BC, Morrow JD et al (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277(48):44877\u201344885. https:\/\/doi.org\/10.1074\/jbc.M206788200","journal-title":"J Biol Chem"},{"issue":"1","key":"1225_CR102","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00109-007-0248-4","volume":"86","author":"AA Izzo","year":"2008","unstructured":"Izzo AA, Aviello G, Petrosino S et al (2008) Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med 86(1):89\u201398. https:\/\/doi.org\/10.1007\/s00109-007-0248-4","journal-title":"J Mol Med"},{"issue":"1","key":"1225_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38865-4","volume":"9","author":"M Grill","year":"2019","unstructured":"Grill M, H\u00f6genauer C, Blesl A et al (2019) Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer. Sci Rep 9(1):2358. https:\/\/doi.org\/10.1038\/s41598-019-38865-4","journal-title":"Sci Rep"},{"key":"1225_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116416","volume":"173","author":"E Faghfuri","year":"2024","unstructured":"Faghfuri E, Gholizadeh P (2024) The role of Akkermansia muciniphila in colorectal cancer: a double-edged sword of treatment or disease progression? Biomed Pharmacother 173:116416. https:\/\/doi.org\/10.1016\/j.biopha.2024.116416","journal-title":"Biomed Pharmacother"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13105-026-01225-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-026-01225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:07:21Z","timestamp":1787285241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13105-026-01225-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1225"],"URL":"https:\/\/doi.org\/10.1007\/s13105-026-01225-8","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"83"}}